Search research articles
Contact Us
Filters
Showing results (21-30 of 120) with videos related to
Page
of 12
Sort By:
Virchows Archiv : an International Journal of Pathology
|
January 29, 2026
HER2-low and HER2-ultra-low salivary gland carcinomas: an exploratory study
Bin Xu, Ahmed Lazim, Dibisha Roy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 28, 2015
Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study
James Nagarajah, Alan L Ho, R Michael Tuttle, et al.
Cancer Treatment Reviews
|
February 19, 2025
Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy
Gabrielle Knafler, Alan L Ho, Kathleen N Moore, et al.
Plos One
|
July 19, 2012
Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype
Alan L Ho, Elgilda Musi, Grazia Ambrosini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 25, 2023
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma
Snjezana Dogan, Bin Xu, Satshil Rana, et al.
Oral Oncology
|
March 26, 2022
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignancies
Bharat Burman, Scott B Drutman, Matthew G Fury, et al.
Molecular Biology of the Cell
|
February 20, 2009
Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780
Jayasree S Nair, Alan L Ho, Archie N Tse, et al.
Head and Neck Pathology
|
November 7, 2024
Targeted RNA Sequencing of Head and Neck Adenoid Cystic Carcinoma Reveals SEC16A::NOTCH1 Fusion and MET Exon 14 Skipping as Potentially Actionable Alterations
Ying-Hsia Chu, Bin Xu, Purvil Sukhadia, et al.
Cancer Research
|
July 13, 2012
PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma
Alan L Ho, Shyamprasad Deraje Vasudeva, Marick Laé, et al.
Journal of Medical Internet Research
|
October 15, 2024
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials
Tony K W Hung, Gilad J Kuperman, Eric J Sherman, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 120) with videos related to
Sort By:
Page
of 12
Virchows Archiv : an International Journal of Pathology
|
January 29, 2026
HER2-low and HER2-ultra-low salivary gland carcinomas: an exploratory study
Bin Xu, Ahmed Lazim, Dibisha Roy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 28, 2015
Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study
James Nagarajah, Alan L Ho, R Michael Tuttle, et al.
Cancer Treatment Reviews
|
February 19, 2025
Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy
Gabrielle Knafler, Alan L Ho, Kathleen N Moore, et al.
Plos One
|
July 19, 2012
Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype
Alan L Ho, Elgilda Musi, Grazia Ambrosini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 25, 2023
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma
Snjezana Dogan, Bin Xu, Satshil Rana, et al.
Oral Oncology
|
March 26, 2022
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus-related malignancies
Bharat Burman, Scott B Drutman, Matthew G Fury, et al.
Molecular Biology of the Cell
|
February 20, 2009
Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780
Jayasree S Nair, Alan L Ho, Archie N Tse, et al.
Head and Neck Pathology
|
November 7, 2024
Targeted RNA Sequencing of Head and Neck Adenoid Cystic Carcinoma Reveals SEC16A::NOTCH1 Fusion and MET Exon 14 Skipping as Potentially Actionable Alterations
Ying-Hsia Chu, Bin Xu, Purvil Sukhadia, et al.
Cancer Research
|
July 13, 2012
PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma
Alan L Ho, Shyamprasad Deraje Vasudeva, Marick Laé, et al.
Journal of Medical Internet Research
|
October 15, 2024
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials
Tony K W Hung, Gilad J Kuperman, Eric J Sherman, et al.
Page
of 12